Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Pimavanserin for Parkinson’s Disease Psychosis: A Meta-analysis of Placebo-controlled Randomized Trials

Author:Petruncio, Matthew George   Pitton Rissardo, Jamir   Elmandouh, Omar   Fornari Caprara, Ana Leticia   Walker, Ian M.   

Session Name:P3: Movement Disorders: Parkinson's Disease Management 1  

Topic:Movement Disorders  

Program Number:P3.013  

Author Institution:Cooper Medical School of Rowan University, NJ  Cooper University Hospital, Camden, NJ  Cooper University Hospital, NJ  

Desensitization Protocol in Patients with Immediate Eptinezumab Hypersensitivity: A Case Series

Author:Vanood, Aimen   Gansert, Emily   Hough, Victoria   Itaaehau, Aimee   Wonnaparhown, Alex   VanderPluym, Juliana   Starling, Amaal   Gonzalez-Estrada, Alexei   

Session Name:P3: Headache: Pharmacological Migraine Prevention 1  

Topic:Headache  

Program Number:P3.013  

Author Institution:Mayo Clinic Arizona, Scottsdale, AZ  Mayo Clinic Florida, FL  Mayo Clinic Alix School of Medicine, AZ  Mayo Clinic Arizona, AZ  

Cardiac CTA Findings in Patients with Acute Ischemic Stroke and Indications for Secondary Stroke Prevention

Author:Milani, Marcus   Chakravarthula, Nitin Ramanujam   Akimoto, Kai   Annam, Saketh   Tessmer, Megan   Staugaitis, Abbey   Markowitz, Jeremy   Kalra, Rajat   Streib, Christopher   

Session Name:P3: Cerebrovascular Disease and Interventional Neurology: Risk and Prevention  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P3.013  

Author Institution:University of Minnesota Medical School, Minneapolis, MN  University of Minnesota, Minneapolis, MN  University of Minnesota Medical School, MN  University of Minnesota, MN  Department of Neurology, Minneapolis, MN  

Neuroprotective Potential of Glucagon-Like Peptide-1 Receptor Agonists in Multiple Sclerosis: A Retrospective Cohort Study Using TriNetX

Author:Irfan, Aayma   Lakin, Lynsey   Khayat-Khoei, Mahsa   

Session Name:P3: Emerging Science 2  

Topic:Multiple Sclerosis  

Program Number:P3.013  

Author Institution:UC Riverside School of Medicine , Redlands, CA  West Coast Neurology, Pomona, CA  UC Riverside Health , Riverside, CA  

Neuroprotective Potential of Glucagon-Like Peptide-1 Receptor Agonists in Multiple Sclerosis: A Retrospective Cohort Study Using TriNetX

Author:Irfan, Aayma   Lakin, Lynsey   Khayat-Khoei, Mahsa   

Session Name:P3: Emerging Science 2  

Topic:Multiple Sclerosis  

Program Number:P3.013  

Author Institution:UC Riverside School of Medicine , Redlands, CA  West Coast Neurology, Pomona, CA  UC Riverside Health , Riverside, CA